{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:24:35Z","timestamp":1790915075497,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82293660\/82293665"],"award-info":[{"award-number":["82293660\/82293665"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Consulting and Research Project of Chinese Academy of Engineering","award":["2019-XY-34"],"award-info":[{"award-number":["2019-XY-34"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To summarize the clinical characteristics of children with adrenocortical carcinoma (ACC) and preliminarily explore the indications for and efficacy of neoadjuvant chemotherapy in certain patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The data of 49 children with adrenocortical tumors (ACT) in the past 15\u00a0years were retrospectively analyzed, and after pathology assessment using Weiss system grading, 40 children diagnosed with ACC were included. Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 and three-dimensional (3D) reconstruction of contrast-enhanced computed tomography data were used to evaluate the response to neoadjuvant chemotherapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Forty patients (17 males, 23 females) with ACC were enrolled. Abnormal hormone levels were common in children with ACC (<jats:italic>n<\/jats:italic>\u2009=\u200931), and in terms of clinical presentation, sexual precocity was the most common (<jats:italic>n<\/jats:italic>\u2009=\u200914, 35.0%), followed by Cushing\u2019s syndrome (<jats:italic>n<\/jats:italic>\u2009=\u200912, 30.0%). Seven of 40 children received neoadjuvant chemotherapy due to a maximum lesion diameter greater than 10\u00a0cm (<jats:italic>n<\/jats:italic>\u2009=\u20094), invasion of surrounding tissues (<jats:italic>n<\/jats:italic>\u2009=\u20092), intravenous tumor thrombus (<jats:italic>n<\/jats:italic>\u2009=\u20092), and\/or distant metastasis (<jats:italic>n<\/jats:italic>\u2009=\u20092); 2 patients achieved partial response, and 5 had stable disease according to the RECIST 1.1 standard. Furthermore, 3D tumor volume reconstruction was performed in 5 children before and after neoadjuvant chemotherapy. Tumor volumes were significantly reduced in all 5 children, with a median volume reduction of 270 (interquartile range, IQR 83, 293) (range: 49\u2013413) ml. After surgery with\/without chemotherapy, the 5-year overall survival rate for all children was 90.0% (95% CI-confidence interval 80.0\u2013100.0%), and the 5-year event-free survival rate was 81.5% (95% CI 68.0\u201397.7%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In the diagnosis and treatment of pediatric ACC, a comprehensive endocrine evaluation is necessary to facilitate early diagnosis. Surgery and chemotherapy are important components of ACC treatment, and neoadjuvant chemotherapy should be considered for children with ACC who meet certain criteria, such as a large tumor, distant metastases, or poor general condition.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-023-01381-3","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T15:01:57Z","timestamp":1696863717000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pediatric adrenocortical carcinoma: clinical features and application of neoadjuvant chemotherapy"],"prefix":"10.1186","volume":"28","author":[{"given":"Yu","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saishuo","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boren","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deguang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,9]]},"reference":[{"issue":"3","key":"1381_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0094-0143(05)70089-6","volume":"27","author":"LS Liou","year":"2000","unstructured":"Liou LS, Kay R. Adrenocortical carcinoma in children. Review and recent innovations. Urol Clin North Am. 2000;27(3):403\u201321.","journal-title":"Urol Clin North Am"},{"issue":"10357","key":"1381_CR2","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/S0140-6736(22)01541-0","volume":"400","author":"X Ni","year":"2022","unstructured":"Ni X, Li Z, Li X, Zhang X, Bai G, Liu Y, et al. Socioeconomic inequalities in cancer incidence and access to health services among children and adolescents in China: a cross-sectional study. Lancet. 2022;400(10357):1020\u201332.","journal-title":"Lancet"},{"key":"1381_CR3","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.2147\/CMAR.S289191","volume":"13","author":"J Li","year":"2021","unstructured":"Li J, Zhang W, Hu H, Zhang Y, Wen Y, Huang D. Adrenocortical carcinoma in eight children: a report and literature review. Cancer Manag Res. 2021;13:1307\u201314.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"1381_CR4","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1245\/s10434-015-4810-y","volume":"23","author":"N Amini","year":"2016","unstructured":"Amini N, Margonis GA, Kim Y, Tran TB, Postlewait LM, Maithel SK, et al. Curative resection of adrenocortical carcinoma: rates and patterns of postoperative recurrence. Ann Surg Oncol. 2016;23(1):126\u201333.","journal-title":"Ann Surg Oncol"},{"issue":"22","key":"1381_CR5","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1200\/JCO.20.02871","volume":"39","author":"C Rodriguez-Galindo","year":"2021","unstructured":"Rodriguez-Galindo C, Krailo MD, Pinto EM, Pashankar F, Weldon CB, Huang L, et al. Treatment of pediatric adrenocortical carcinoma with surgery, retroperitoneal lymph node dissection, and chemotherapy: the children\u2019s oncology group ARAR0332 protocol. J Clin Oncol. 2021;39(22):2463\u201373.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1381_CR6","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.path.2019.08.010","volume":"12","author":"A Vaidya","year":"2019","unstructured":"Vaidya A, Nehs M, Kilbridge K. Treatment of adrenocortical carcinoma. Surg Pathol Clin. 2019;12(4):997\u20131006.","journal-title":"Surg Pathol Clin"},{"issue":"3","key":"1381_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/00000478-198403000-00001","volume":"8","author":"LM Weiss","year":"1984","unstructured":"Weiss LM. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol. 1984;8(3):163\u20139.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"1381_CR8","doi-asserted-by":"publisher","first-page":"e27567","DOI":"10.1002\/pbc.27567","volume":"66","author":"S Jehangir","year":"2019","unstructured":"Jehangir S, Nanjundaiah P, Sigamani E, Burad D, Manipadam MT, Lea V, et al. Pathological prognostication of paediatric adrenocortical tumours: is a gold standard emerging? Pediatr Blood Cancer. 2019;66(4):e27567.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"1381_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/cncr.24030","volume":"115","author":"M Fassnacht","year":"2009","unstructured":"Fassnacht M, Johanssen S, Quinkler M, Bucsky P, Willenberg HS, Beuschlein F, et al. Limited prognostic value of the 2004 international union against cancer staging classification for adrenocortical carcinoma: proposal for a revised TNM classification. Cancer. 2009;115(2):243\u201350.","journal-title":"Cancer"},{"issue":"7","key":"1381_CR10","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.jtho.2018.04.034","volume":"13","author":"SG Armato 3rd","year":"2018","unstructured":"Armato SG 3rd, Nowak AK. Revised modified response evaluation criteria in solid tumors for assessment of response in malignant pleural mesothelioma (version 1.1). J Thorac Oncol. 2018;13(7):1012\u201321.","journal-title":"J Thorac Oncol"},{"key":"1381_CR11","doi-asserted-by":"publisher","first-page":"6302","DOI":"10.1038\/ncomms7302","volume":"6","author":"EM Pinto","year":"2015","unstructured":"Pinto EM, Chen X, Easton J, Finkelstein D, Liu Z, Pounds S, et al. Genomic landscape of paediatric adrenocortical tumours. Nat Commun. 2015;6:6302.","journal-title":"Nat Commun"},{"issue":"6","key":"1381_CR12","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1200\/JCO.2013.52.6863","volume":"33","author":"JD Wasserman","year":"2015","unstructured":"Wasserman JD, Novokmet A, Eichler-Jonsson C, Ribeiro RC, Rodriguez-Galindo C, Zambetti GP, et al. Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children\u2019s oncology group study. J Clin Oncol. 2015;33(6):602\u20139.","journal-title":"J Clin Oncol"},{"issue":"Suppl 4","key":"1381_CR13","doi-asserted-by":"publisher","first-page":"e29025","DOI":"10.1002\/pbc.29025","volume":"68","author":"C Virgone","year":"2021","unstructured":"Virgone C, Roganovic J, Vorwerk P, Redlich A, Schneider DT, Janic D, et al. Adrenocortical tumours in children and adolescents: The EXPeRT\/PARTNER diagnostic and therapeutic recommendations. Pediatr Blood Cancer. 2021;68(Suppl 4):e29025.","journal-title":"Pediatr Blood Cancer"},{"key":"1381_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26368","author":"G Cecchetto","year":"2017","unstructured":"Cecchetto G, Ganarin A, Bien E, Vorwerk P, Bisogno G, Godzinski J, et al. Outcome and prognostic factors in high-risk childhood adrenocortical carcinomas: a report from the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT). Pediatric Blood Cancer. 2017. https:\/\/doi.org\/10.1002\/pbc.26368.","journal-title":"Pediatric Blood Cancer"},{"key":"1381_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jsbmb.2019.01.018","volume":"190","author":"J Rege","year":"2019","unstructured":"Rege J, Turcu AF, Else T, Auchus RJ, Rainey WE. Steroid biomarkers in human adrenal disease. J Steroid Biochem Mol Biol. 2019;190:273\u201380.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"1381_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrendo.2010.217","volume":"7","author":"MO Goodarzi","year":"2011","unstructured":"Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7(4):219\u201331.","journal-title":"Nat Rev Endocrinol"},{"key":"1381_CR17","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2147\/IJWH.S403347","volume":"15","author":"S Alhassan","year":"2023","unstructured":"Alhassan S, Elmugadam A, Elfadil GA, Abubaker N, Elfaki EM, Hamza A, et al. Diagnostic performance of anti-M\u00fcllerian hormone, luteinizing hormone to follicle-stimulating hormone ratio, testosterone, and prolactin to predict polycystic ovary syndrome among Sudanese women. Int J Women\u2019s Health. 2023;15:837\u201343.","journal-title":"Int J Women\u2019s Health"},{"issue":"2","key":"1381_CR18","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1210\/er.2013-1029","volume":"35","author":"T Else","year":"2014","unstructured":"Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, et al. Adrenocortical carcinoma. Endocr Rev. 2014;35(2):282\u2013326.","journal-title":"Endocr Rev"},{"issue":"7","key":"1381_CR19","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1097\/00000478-200307000-00001","volume":"27","author":"JA Wieneke","year":"2003","unstructured":"Wieneke JA, Thompson LD, Heffess CS. Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients. Am J Surg Pathol. 2003;27(7):867\u201381.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1381_CR20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jpedsurg.2015.10.039","volume":"51","author":"BC Gulack","year":"2016","unstructured":"Gulack BC, Rialon KL, Englum BR, Kim J, Talbot LJ, Adibe OO, et al. Factors associated with survival in pediatric adrenocortical carcinoma: an analysis of the national cancer data base (NCDB). J Pediatr Surg. 2016;51(1):172\u20137.","journal-title":"J Pediatr Surg"},{"issue":"5","key":"1381_CR21","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.surg.2020.10.041","volume":"169","author":"F Zhang","year":"2021","unstructured":"Zhang F, Liu Z, Liang J, Tang Y, Liu S, Zhou C, et al. Operative intervention for recurrence of adrenocortical carcinoma: a single-center experience. Surgery. 2021;169(5):1131\u20138.","journal-title":"Surgery"},{"issue":"3","key":"1381_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11912-019-0773-7","volume":"21","author":"S Jasim","year":"2019","unstructured":"Jasim S, Habra MA. Management of adrenocortical carcinoma. Curr Oncol Rep. 2019;21(3):20.","journal-title":"Curr Oncol Rep"},{"issue":"203","key":"1381_CR23","first-page":"109","volume":"127","author":"F Megerle","year":"2019","unstructured":"Megerle F, Kroiss M, Hahner S, Fassnacht M. Advanced adrenocortical carcinoma\u2014what to do when first-line therapy fails? Exp Clin Endocrinol Diabetes. 2019;127(203):109\u201316.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"1381_CR24","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1007\/s00268-014-2484-4","volume":"38","author":"BK Bednarski","year":"2014","unstructured":"Bednarski BK, Habra MA, Phan A, Milton DR, Wood C, Vauthey N, et al. Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy. World J Surg. 2014;38(6):1318\u201327.","journal-title":"World J Surg"},{"issue":"3","key":"1381_CR25","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1677\/erc.1.01025","volume":"12","author":"A Berruti","year":"2005","unstructured":"Berruti A, Terzolo M, Sperone P, Pia A, Della Casa S, Gross DJ, et al. Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial. Endocr Relat Cancer. 2005;12(3):657\u201366.","journal-title":"Endocr Relat Cancer"},{"key":"1381_CR26","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-22-0259","author":"M Riedmeier","year":"2023","unstructured":"Riedmeier M, Thompson LDR, Molina CAF, Decarolis B, H\u00e4rtel C, Schlegel PG, et al. Prognostic value of the Weiss and Wieneke (AFIP) scoring systems in pediatric ACC\u2014a mini review. Endocr Relat Cancer. 2023. https:\/\/doi.org\/10.1530\/ERC-22-0259.","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"1381_CR27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.2350\/08-06-0489.1","volume":"12","author":"LP Dehner","year":"2009","unstructured":"Dehner LP, Hill DA. Adrenal cortical neoplasms in children: why so many carcinomas and yet so many survivors? Pediatric Dev Pathol. 2009;12(4):284\u201391.","journal-title":"Pediatric Dev Pathol"},{"issue":"4","key":"1381_CR28","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41379-018-0174-8","volume":"32","author":"C Picard","year":"2019","unstructured":"Picard C, Orbach D, Carton M, Brugieres L, Renaudin K, Aubert S, et al. Revisiting the role of the pathological grading in pediatric adrenal cortical tumors: results from a national cohort study with pathological review. Modern Pathol. 2019;32(4):546\u201359.","journal-title":"Modern Pathol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01381-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01381-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01381-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T22:27:51Z","timestamp":1700519271000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01381-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,9]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1381"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01381-3","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,9]]},"assertion":[{"value":"16 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. This retrospective study was approved by the Medical Ethics Committee of the Beijing Children\u2019s Hospital [2022]-E-211-R, and the family\/patient informed consent requirements were waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors has any source of financial or other support, or any financial of professional relationship that may pose a competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"411"}}